Nanotechnology in Drug Delivery Systems

Using tiny carriers at the nanoscale helps improve how well drugs dissolve, stay stable, get absorbed by the body, and release over time. Nanotechnology-based approaches have emerged as promising strategies for improving drug delivery. Nanotechnology-based drug delivery systems can facilitate the delivery of drugs to specific tissues or cells, potentially reducing adverse effect on healthy tissues. Various nanocarriers, including liposomes, polymeric nanoparticles, micelles, dendrimers, and lipid-based nanoparticles, have been investigated for their potential therapeutic applications. These systems have potential applications in cancer treatment, gene and vaccine delivery, neurological disorders, infectious diseases, and theranostics, which combines therapeutic and dignostics approaches. Despite these potential benefits, challenges remain regarding toxicity, biocompatibility, long-term stability, large-scale manufacturing, regulatory requirements, and clinical translation. Further research is needed to establish the safety, efficacy, and clinical applicability of nanotechnology-based drug delivery systems.